EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells

Angelo Michilli iD, Cristian Bassi, Farzaneh Moshiri, Bruno De Siena, Rosaria Marinaro, Elisa Callegari, Massimo Negrini, Silvia Sabbioni

BioTech · 11.02.2026 · 15 (1) · 18

DOI: 10.3390/biotech15010018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioTech, online erschienen am 11.02.2026. Verfasst von Angelo Michilli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research, University of Ferrara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the advent of immune checkpoint inhibitor-based regimens, sorafenib remains an important therapeutic option for patients with advanced hepatocellular carcinoma (HCC) who are ineligible for immunotherapy. However, its clinical efficacy is limited by the emergence of drug resistance, whose underlying molecular mechanisms remain incompletely understood. To investigate these mechanisms, we established a murine model of acquired sorafenib resistance and performed comparative RNA sequencing of sorafenib-sensitive versus -resistant Hep55.1C hepatoma cells. Transcriptomic profiling revealed a distinct resistance-associated signature comprising 1264 significantly deregulated genes (adjusted p < 0.03, fold change > 3.0). Pathway analysis and Gene Set Enrichment Analyses (GSEA) indicated a coordinated downregulation of metabolic and intercellular signaling pathways, accompanied by marked upregulation of redox-regulatory, mitochondrial and cellular stress-response programs. Genes transcriptionally regulated by nuclear factor erythroid 2-related factor 2 (NRF2) including Gpx4, Txn1, Txnrd1, Hmox1, Fth1, Taldo1, Phgdh, and MafG, involved in antioxidant defense, ferroptosis suppression and metabolic rewiring, were all upregulated in resistant cells. Pharmacological inhibition of NRF2 activity using brusatol restored sensitivity to sorafenib, functionally implicating NRF2-dependent pathways in the maintenance of the resistant phenotype. These findings demonstrate that acquired sorafenib resistance in HCC is associated with a stable NRF2-driven transcriptional and metabolic reprogramming that enhances antioxidant capacity, suppresses ferroptosis and promotes tumor cell survival. Targeting NRF2-regulated redox metabolism may therefore represent a promising strategy to overcome therapeutic resistance in HCC.

Schlagwörter

Stichwörter der Autor:innen

NRF2hepatocellular carcinomaoxidative stressredox metabolismsorafenib resistancetranscriptomics

Autor:innen und Institutionen

  • Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), University of Ferrara, 44121 Ferrara, Italy.
  • Center for Molecular Biology (CDBM), Ferrara University Hospital, 44124 Ferrara, Italy.

ORCID-Profile: Angelo Michilli

Förderung

  • Italian Ministry of University and Research
  • University of Ferrara

Zitieren

APA

Michilli, A., Bassi, C., Moshiri, F., De Siena, B., Marinaro, R., Callegari, E., Negrini, M., & Sabbioni, S. (2026). Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells. BioTech, 15(1), 18. https://doi.org/10.3390/biotech15010018

Vancouver

Michilli A, Bassi C, Moshiri F, De Siena B, Marinaro R, Callegari E, et al. Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells. BioTech. 2026;15(1):18. doi:10.3390/biotech15010018

BibTeX
@article{Michilli2026,
  author = {Michilli, Angelo and Bassi, Cristian and Moshiri, Farzaneh and De Siena, Bruno and Marinaro, Rosaria and Callegari, Elisa and Negrini, Massimo and Sabbioni, Silvia},
  title = {Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells},
  journal = {BioTech},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {18},
  doi = {10.3390/biotech15010018}
}
Kostenlos starten →